[go: up one dir, main page]

IL188848A - Transient receptor potential type i (trpvi )antagonist, pharmaceutical composition containing it for the treatment of diseases and associated conditions - Google Patents

Transient receptor potential type i (trpvi )antagonist, pharmaceutical composition containing it for the treatment of diseases and associated conditions

Info

Publication number
IL188848A
IL188848A IL188848A IL18884808A IL188848A IL 188848 A IL188848 A IL 188848A IL 188848 A IL188848 A IL 188848A IL 18884808 A IL18884808 A IL 18884808A IL 188848 A IL188848 A IL 188848A
Authority
IL
Israel
Prior art keywords
trpvi
antagonist
diseases
treatment
pharmaceutical composition
Prior art date
Application number
IL188848A
Other languages
Hebrew (he)
Other versions
IL188848A0 (en
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2006/002016 external-priority patent/WO2007010383A1/en
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of IL188848A0 publication Critical patent/IL188848A0/en
Publication of IL188848A publication Critical patent/IL188848A/en

Links

IL188848A 2005-07-22 2008-01-17 Transient receptor potential type i (trpvi )antagonist, pharmaceutical composition containing it for the treatment of diseases and associated conditions IL188848A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005213534 2005-07-22
PCT/IB2006/002016 WO2007010383A1 (en) 2005-07-22 2006-07-24 Novel heterocyclidene acetamide derivative

Publications (2)

Publication Number Publication Date
IL188848A0 IL188848A0 (en) 2008-04-13
IL188848A true IL188848A (en) 2015-06-30

Family

ID=39859556

Family Applications (1)

Application Number Title Priority Date Filing Date
IL188848A IL188848A (en) 2005-07-22 2008-01-17 Transient receptor potential type i (trpvi )antagonist, pharmaceutical composition containing it for the treatment of diseases and associated conditions

Country Status (3)

Country Link
CN (1) CN101228131B (en)
IL (1) IL188848A (en)
ZA (1) ZA200800959B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102786515B (en) * 2012-04-13 2014-07-23 湖南大学 2-(2, 2-dimethyl-2, 3-dihydrobenzofuran-5-group)morpholine and preparation method and application
JP6230743B1 (en) * 2017-05-31 2017-11-15 持田製薬株式会社 Crystals of heterocyclideneacetamide derivatives
CA3150748A1 (en) 2019-08-23 2021-03-04 Mochida Pharmaceutical Co., Ltd. Method for producing heterocyclidene acetamide derivative
CA3156484A1 (en) * 2019-10-04 2021-04-08 Senju Pharmaceutical Co., Ltd. Pharmaceutical drug containing heterocyclidene acetamide derivative
WO2025161263A1 (en) * 2024-01-31 2025-08-07 深圳晶蛋生物医药科技有限公司 Benzomorpholine compound and use thereof

Also Published As

Publication number Publication date
CN101228131B (en) 2013-01-09
CN101228131A (en) 2008-07-23
IL188848A0 (en) 2008-04-13
ZA200800959B (en) 2009-10-28

Similar Documents

Publication Publication Date Title
WO2007111864A3 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
WO2007136577A3 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
UA96308C2 (en) Glucagon receptor antagonist compounds, composition comprising such compounds and use thereof
IL178775A0 (en) Pharmaceutical compositions for acute glucocorticoid therapy
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
IL185761A0 (en) Pharmaceutical compositions for treating diabetes
PL2054411T3 (en) Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
IL199397A (en) Heterocyclic compounds, pharmaceutical compositions comprising them and medical uses thereof
ZA200901110B (en) Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage from containing same
CL2007002017A1 (en) COMPOUNDS DERIVED FROM [4,5 '] - BIPIRIMIDINIL-6,4'-DIAMINE; PHARMACEUTICAL COMPOSITION; AND USE AS AN INHIBITOR OF THE ACTIVITY OF CINASA IN CANCER DE VEJIGA, CANCER CERVICAL AND MIELOMA MULTIPLE.
WO2008021851A3 (en) Novel compounds as antagonists or inverse agonists for opioid receptors
IL185277A0 (en) Pharmaceutical compositions containing roflumilast for the treatment of diabetes
MX2009006704A (en) New compounds.
LTC1781298I2 (en) Pharmaceutical compositions containing benzoxazine for the treatment of respiratory diseases
WO2009071689A3 (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
PT1701698E (en) Directly compressible pharmaceutical composition for the oral admimistration of cci-779
ZA200805761B (en) Pharmaceutical composition for the treatment of nail disease
IL178776A0 (en) Pharmaceutical compositions for glucocorticoid replacement therapy
EP1861358A4 (en) Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist, and pharmaceutical compositions containing the same
IL188848A (en) Transient receptor potential type i (trpvi )antagonist, pharmaceutical composition containing it for the treatment of diseases and associated conditions
IL178067A0 (en) Pharmaceutical dosage forms and compositions
IL179530A0 (en) Novel compounds, pharmaceutical compositions containing same and methods of use for same
IL198634A0 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
IL191457A0 (en) Pharmaceutical compositions containing steroid derivatives
IL189827A0 (en) Pharmaceutical dosage forms and compositions comprising lecoztan

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed